(2023-2028) Heparin Market Size, Demand Analysis, Growth, Top Companies and Forecast Report

IMARC Group's latest research report, titled "Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," The global heparin market size reached US$ 7.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.4% during 2023-2028.

Get Free Sample Copy of Report at - https://www.imarcgroup.com/heparin-market/requestsample

Heparin Market Overview:

Heparin refers to a mucopolysaccharide that has antithrombotic properties and acts as an anticoagulant or a blood thinner in pharmaceuticals. It is composed of chains of sugar molecules and is primarily produced by mast cells in the lining of blood vessels and by the liver. It functions by inactivating thrombin and preventing the conversion of fibrinogen to fibrin which prevents the clots from becoming larger and causing more serious problems. It is available in several forms, including unfractionated heparin and low molecular-weight heparin. It is widely used therapeutically as an injectable medication to prevent or treat blood clots in conditions, such as deep vein thrombosis, pulmonary embolism, and stroke. It is also utilized during surgeries and medical procedures to prevent the formation of blood clots.

Global Heparin Market Demand and Future Growth Analysis:

The global market is primarily driven by the increasing prevalence of various cardiovascular and pulmonary diseases, such as deep vein thrombosis, pulmonary embolism, and arterial thrombosis. Moreover, the growing demand for heparin in numerous surgical procedures and dialysis treatments is catalyzing the growth of the market. In line with this, the rising healthcare expenditure, along with the growing government investments in enhancing healthcare services on the global level, are acting as other growth-inducing factors.

Furthermore, several major companies are developing innovative medicines to enhance the therapeutic potential of heparin and reduce its side effects, thus creating a positive market outlook. Other factors, including the rising geriatric population, continuous technological advancements, and growing demand for low-molecular-weight heparin, are projected to propel the market further.

Do you know more information, Contact to our analyst at- https://www.imarcgroup.com/heparin-market

Key Market Segmentation:

Top Heparin Companies Worldwide:

• GlaxoSmithKline
• Hepalink
• Pfizer
• LeoPharma
• Sanofi
• Reddy's Laboratories
• Teva Pharmaceutical Industries
• Aspen
• LEO Pharma
• Baxter
• Changshan Pharm
• Sandoz
• Opocrin
• Deebio
• Tiandong

Breakup by Product:

• Unfractionated Heparin
• Low Molecular Weight Heparin (LMWH)
• Ultra-low Molecular Weight Heparin (ULMWH)

Breakup by Source:

• Bovine
• Porcine

Breakup by Mode of Administration:

• Oral
• Parenteral

Breakup by Application:

• Atrial Fibrillation & Heart Attack
• Stroke
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Others

Breakup by End-User:

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Stores
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.